Cutaneous squamous cell carcinoma derived cell lines are more sensitive to the proteasome inhibitor bortezomib than normal skin cells

L. Koerver, Z. H. Tura, I. M. Leigh, A. P. South, M. K. Saville

    Research output: Contribution to journalMeeting abstractpeer-review

    Original languageEnglish
    Pages (from-to)S183
    Number of pages1
    JournalJournal of Investigative Dermatology
    Issue numberS1
    Publication statusPublished - 2013
    EventInternational Investigative Dermatology Meeting - Edinburgh, United Kingdom
    Duration: 8 May 201311 May 2013

    Cite this